Clinical Trial Update: Study to Assess the Efficacy and Safety of AZD1981 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating AZD1981 for efficacy and safety in moderate to severe chronic obstructive pulmonary disease has completed; results were posted in Decem…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• AZD1981

Snippet

Sponsor: AstraZeneca | Conditions: Moderate to Severe COPD | Phase 2 | Status: COMPLETED | Results posted: 2013-12-06